Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Andrew's Options

<< Previous

Bullboard Posts

Next >>

Comment by 2O2Ovisionon Nov 20, 2023 10:12am

226 Views

Post# 35744165

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Andrew's Options

I can't vouch for the accuracy of Yahoo or any other of these investor sites but anyone taking a serious look at canadian companies should be looking at the source on Sedi. Simply search "sedi summary report" and you'll be able to filter by issuer on the website (just type oncolytics) for any desired date range. It generate a free public report to suit whatever you're looking for. Furthermore, as I posted earlier, the canadainsider site provides up to date trades, and the year end reports on the company website lists all the expiry dates. Hope this helps anyone who may not have known where to find the info. Cheers.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December